Treatment In Thoracic Aortic Aneurysm: Surgery versus Surveillance

Treatment In Thoracic Aortic Aneurysm: Surgery versus Surveillance
Enrolling By Invitation
18 years - 79 years
All
Phase N/A
30 participants needed
1 Location

Brief description of study

This study aims to compare the outcomes of patients undergoing early surgical intervention for ascending aortic aneurysms to those undergoing aneurysm surveillance.

Patients with aneurysm diameters between 5.0 and 5.4 cm will be randomized to receive either medical therapy or elective surgery and will be followed annually for 5 years. The second arm of this study will establish a history registry of patients with aneurysms greater than 5.5 cm who refuse surgery or are not surgical candidates. Subjects will be screened via clinic appointments with investigators within the Division of Cardiovascular Surgery. Based on medical history and surgeon recommendations, eligible patients will then be contacted either in-person during clinic or over the phone to discuss participation interest.

This trial will include patients diagnosed with an asymptomatic ascending aortic aneurysm between 5.0 and 5.4 cm in maximal diameter.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: aortic aneurysm,surgery
  • Age: 18 years - 79 years
  • Gender: All


Updated on 01 Aug 2024. Study ID: 834600
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research